NEW YORK -- SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”) which beneficially owns approximately 15% of the Company’s outstanding common shares, urged shareholders to immediately vote “FOR” the election of SAIF Partners’ ten highly qualified director candidates to the Company’s Board of Directors (the “Board&rdqu ...